Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pigment Dispersion Glaucoma”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Not applicableStudy completedNCT02165631
What this trial is testing

The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

Who this might be right for
Open Angle GlaucomaOcular HypertensionPigment Dispersion Syndrome+1 more
University of Colorado, Denver 60
Not applicableStudy completedNCT00001161
What this trial is testing

Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens

Who this might be right for
AniridiaEye AbnormalityOcular Hypertension+1 more
National Eye Institute (NEI) 100
Post-approval studies (Phase 4)Study completedNCT01336569
What this trial is testing

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Who this might be right for
Glaucoma
Alcon Research 50
Large-scale testing (Phase 3)WithdrawnNCT00862472
What this trial is testing

Safety and Efficacy Study of DuoTrav APS Versus DuoTrav

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research
Post-approval studies (Phase 4)Ended earlyNCT01514734
What this trial is testing

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

Who this might be right for
Glaucoma
Alcon Research 9
Post-approval studies (Phase 4)Study completedNCT01471158
What this trial is testing

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Who this might be right for
Glaucoma
Alcon Research 120
Not applicableLooking for participantsNCT06682962
What this trial is testing

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

Who this might be right for
GlaucomaPrimary Open Angle GlaucomaPseudoexfoliation Glaucoma+2 more
Okuvision GmbH 50
Post-approval studies (Phase 4)Study completedNCT01415401
What this trial is testing

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

Who this might be right for
GlaucomaOcular HypertensionOpen-angle Glaucoma
Alcon Research 57
Not applicableUnknownNCT00347893
What this trial is testing

The Efficacy of Selective Laser Trabeculoplasty

Who this might be right for
Primary Open Angle GlaucomaOcular HypertensionPseudo-Exfoliative Glaucoma+1 more
Glaucoma Research & Education Group
Post-approval studies (Phase 4)Ended earlyNCT01514721
What this trial is testing

Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy

Who this might be right for
Glaucoma
Alcon Research 37
Post-approval studies (Phase 4)Study completedNCT01518244
What this trial is testing

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America

Who this might be right for
Glaucoma
Alcon Research 50
Not applicableStudy completedNCT02628223
What this trial is testing

180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma

Who this might be right for
Open Angle GlaucomaOcular HypertensionGlaucoma, Open Angle, Pseudo-exfoliative+2 more
Temple University 76
Not applicableStudy completedNCT01053416
What this trial is testing

Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser Iridotomy

Who this might be right for
Pigment Dispersion Syndrome
University of Parma 72
Not applicableStudy completedNCT00005919
What this trial is testing

Cause of Pigment Dispersion Syndrome

Who this might be right for
GlaucomaHealthyPigment Dispersion Syndrome
National Eye Institute (NEI) 90
Not applicableStudy completedNCT00001152
What this trial is testing

Pigment Dispersion Syndrome With and Without Glaucoma

Who this might be right for
GlaucomaGlaucoma, Open-AngleOcular Hypertension
National Eye Institute (NEI) 175
Post-approval studies (Phase 4)Study completedNCT01484951
What this trial is testing

AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

Who this might be right for
Glaucoma
Alcon Research 74
Post-approval studies (Phase 4)Study completedNCT00372827
What this trial is testing

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular HypertensionPigment Dispersion Glaucoma
Alcon Research 245
Not applicableUnknownNCT05231928
What this trial is testing

A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome

Who this might be right for
Pigment Dispersion SyndromePigmentary Glaucoma
Fayoum University 10
Not applicableUnknownNCT04609345
What this trial is testing

Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients

Who this might be right for
Primary Open-angle GlaucomaPrimary Angle-Closure GlaucomaPseudoexfoliation Glaucoma+2 more
Santen Pharma Malaysia Sdn Bhd 400
Load More Results